Ab182808

antibody from Aladdin Scientific
Targeting: IL13 ALRH, BHR1, IL-13, MGC116786, MGC116788, MGC116789, P600
Provider product page for Ab182808
No application information provided.

Antibody data

Product number
Ab182808 - Provider product page
Provider
Aladdin Scientific
Product name
Cendakimab (anti-IL-13)
Antibody type
Recombinant
Description
Cendakimab (anti-IL-13) is a selective, humanized, recombinant monoclonal antibody against the IL-13 molecule. Cendakimab (anti-IL-13) has a high affinity and potency for both human wild-type and variant IL-13 and blocks binding of IL-13 to both IL-13R_1 and IL-13R_2 with IC50s of 352 pM and 631 pM by ELISA, respectively. Cendakimab (anti-IL-13) recognizes both wild-type human IL-13 and the common polymorphic variant R110Q, with binding affinities of 52 and 50 pM, respectively. Cendakimab (anti-IL-13) has the potential for IL-13-related allergic/inflammatory diseases (e.g., asthma and eosinophilic esophagitis).Purity>95% (SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg
Reactivity
Human
Conjugate
Unconjugated
Vial size
100_g,10mg,1mg,5mg
Concentration
Lot by Lot
Storage
Store at -80_ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
IL13 protein structure - Ab182808 shown in red.